Beclometasone dipropionate (anhydrous).
Each puff (metered dose) of Beclazone 50 micrograms CFC-Free Inhaler contains 50 micrograms of beclometasone dipropionate.
Each puff (metered dose) of Beclazone 250 micrograms CFC-Free Inhaler contains 250 micrograms of beclometasone dipropionate.
The other ingredients are ethanol anhydrous (alcohol) and the propellant norflurane (HFA-134a). This medicine does not contain any CFCs.
Effect: Beclazone CFC-Free Inhaler contains Beclometasone Dipropionate, which belongs to a group of medicines called corticosteroids. Beclometasone dipropionate works on the lungs to help prevent asthma attacks by reducing the swelling and irritation in the walls of the small air passages. This eases the breathing problems. Very little corticosteroid gets absorbed into the body. This medicine is not the same type of steroid used by body-builders and athletes to increase their performance.
Beclazone CFC-Free Inhalers are used to treat asthma. This type of medicine is known as a 'preventer'. The patient must keep on taking this type of medicine regularly, even when the patient do not seem to have the asthma symptoms.
The patient should not use this inhaler to relieve wheezing or breathlessness. The patient will probably need a different kind of medicine in a different coloured pack for this purpose. The patient may be using an inhaler that widens the airways during an asthma attack. This type of inhaler is known as a 'reliever'. The patient can safely use the 'reliever' with the Beclazone CFC-Free Inhaler.
Always take Beclazone CFC-Free Inhaler exactly as the doctor has told to the patient. The patient should check with the doctor or pharmacist if not sure.
All patients are different and the doctor may have prescribed a different dose for the patient.
The usual dose for Because CFC-Free Inhaler is: Adults and the elderly: Beclazone 50 micrograms CFC-Free Inhaler: Take one to two puffs twice daily.
Usually the most the patient would take in 24 hours is sixteen puffs.
Beclazone 250 micrograms CFC-Free Inhaler: Take one to two puffs twice daily.
Usually the most the patient would take in 24 hours is four puffs.
Children seven years and older: Beclazone 50 micrograms CFC-Free Inhaler: Take one or two puffs twice daily.
Usually the most the patient would take in 24 hours is four puffs.
Beclazone 250 micrograms CFC-Free Inhaler is not recommended for use in children.
Hepatic or renal impairment: Dose adjustments are not required. Follow the doctor's instructions.
If the patient forgets to take Beclazone CFC-Free Inhaler: Do not take a double dose to make up for a forgotten dose. If the patient forgets to use the inhaler, take the recommended number of puffs when remembered. Then continue the treatment as prescribed by the doctor.
If the patient takes more Beclazone CFC-Free Inhaler than it should: The dose has been carefully worked out for the patient. It is important that the patient do not take too much. If the patient accidentally takes more puffs than the doctor has recommended, don't worry. However, if the patient regularly uses more than the recommended dose, the patient should tell the doctor as soon as possible.
Do not use Beclazone CFC-Free Inhaler: If the patient is allergic to beclometasone dipropionate (active ingredient) or to any of the other ingredients of Beclazone CFC-Free Inhaler.
If the patient suffers from or has ever suffered from tuberculosis (TB).
Because the inhaler is used to prevent asthma attacks, it is important to use it regularly, even when the patient feels well.
It may take a few days for the medicine to work. Do not stop using the inhaler unless told by a doctor.
If the patient has started to use Beclazone CFC-Free Inhaler with, or instead of, taking steroid tablets the patient should carry a steroid warning card (if the patient has one) until the doctor tells the patient to no longer need to carry it.
Consult a doctor immediately if the usual treatment is not working. The doctor will tell if the patient needs any extra treatment. The dosage should only be increased on medical advice.
If the patient notices more short of breath and wheeze is getting worse, tell the doctor immediately.
He or she will tell if the patient needs any extra treatment.
Driving and using machines: Beclazone CFC-Free Inhaler dose not affect the ability to drive or to use machinery.
Pregnancy and breast-feeding: Ask the doctor or pharmacist for advice before taking any medicine. Beclazone CFC-Free Inhaler should only be used if recommended by a doctor.
Like all medicines Beclazone CFC-Free Inhaler can cause side effects, although not everybody gets them.
Contact the doctor immediately if the patient experiences hypersensitivity (allergic) reactions. These include rash, swelling of the face, eyes, lips and throat and wheezing (because of narrowed airways).
Infections and infestations: Common side effects (affecting more than 1 in 100 and less than 1 in 10 individuals): Candidiasis (thrush) in the mouth and throat, which is seen as white spots. Rinsing the mouth with water immediately after using the inhaler will help prevent this from occurring. If the patient has these symptoms, tell the doctor but do not stop using the inhaler unless the doctor told to.
Immune system disorders: Rare side effects (affecting more than 1 in 10,000 and less than 1 in 1,000 individuals): Hypersensitivity reactions as described previously.
Respiratory, thoracic and mediastinal disorders: Common side effects (affecting more than 1 in 100 and less than 1 in 10 individuals): Hoarseness and throat irritation.
Rare side effects (affecting more than 1 in 10,000 and less than 1 in 1,000 individuals): Wheezing, difficulty in breathing or tightness in the chest. If this happens, stop using the inhaler and tell the doctor immediately.
Skin and subcutaneous tissue disorders: Very rare side effects (affecting less than 1 in 10,000 individuals including isolated reports): Itching, rash and reddening of the skin.
Musculoskeletal and connective tissue disorders: Very rare side effects (affecting less than 1 in 10,000 individuals including isolated reports): Decreased bone density.
Endocrine disorders: Very rare side effects (affecting less than 1 in 10,000 individuals including isolated reports): Decrease in function of the adrenal gland, which is responsible for producing some hormones that control the body. Decrease in growth, particularly in children and adolescents.
Eye disorders: Very rare side effects (affecting less than 1 in 10,000 individuals including isolated reports): Cataracts (formation of a film over the eye lens). Glaucoma (a disease in which the eye pressure increases).
If any of the side effects get serious, or if the patient notices any side effects not listed, please tell the doctor or pharmacist.
Please tell the doctor or pharmacist if the patient is taking or has recently taken any other medicines, including medicines that are obtained without a prescription.
The following medicines may influence the effect of Beclazone CFC-Free Inhaler: Other asthma medicines, such as bronchodilators, or other corticosteroids in tablet form.
Taking Beclazone CFC-Free Inhaler with food or drink: Beclazone CFC-Free Inhaler should be used as prescribed by the doctor.
Medicines should not be disposed of via wastewater or household waste. Ask the pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Do not store above 25°C.
Do not refrigerate or freeze. If the inhaler gets very cold, remove the metal can and warm it in the hands for a few minutes before using it. Do not warm the can in any other way. Pressurized aerosol can. Do not expose to temperatures higher than 50°C. Do not puncture, break or burn the can, even if it seems empty.
R03BA01 - beclometasone ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, glucocorticoids.
Beclazone 250 CFC-Free inhaler 250 mcg/actuation
200 actuation x 1's
Beclazone 50 CFC-Free inhaler 50 mcg/actuation
200 actuation x 1's